Evidence map›Paper›PMID 41419753›Full record

Observational studyScientific reports2025

Low-grade, systemic inflammation and the risk of perioperative neurocognitive disorders in an observational study of older adults.

Insa Feinkohl, Daniel Hadzidiakos, Thomas B Dschietzig, Jürgen Janke, Maria Heinrich, Arjen J C Slooter, Claudia Spies, Georg Winterer, Tobias Pischon

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02265263 (Biomarker Development for Postoperative Cognitive Impairment in the Elderly), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02265263 terminatednot on this map

Biomarker Development for Postoperative Cognitive Impairment in the Elderly (BioCog)

TypeobservationalSponsorCharite University, Berlin, GermanyRan2014 to 2019Enrolled1,054ConditionsPostoperative Delirium (POD), Postoperative Cognitive Deficit (POCD)
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Insa Feinkohl *Epidemiology Research Group, Faculty of Health Sciences Brandenburg, University of Potsdam, Potsdam, Germany. insa.feinkohl@uni-potsdam.de.
Daniel Hadzidiakos *Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Thomas B DschietzigImmundiagnostik AG, Berlin, Germany.
Jürgen JankeMolecular Epidemiology Research Group, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Maria HeinrichCharité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Arjen J C SlooterDepartment of Intensive Care Medicine and UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Claudia SpiesCharité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Georg WintererCharité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Tobias PischonMolecular Epidemiology Research Group, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims The neuroinflammatory response to surgery may contribute to the pathogenesis of post-operative delirium (POD) and cognitive dysfunction (POCD), but whether inflammation before surgery enhances the risk of developing these conditions is unclear. Here, we investigate the relationship between preoperative levels of inflammation markers and the risk of POD/POCD. Methods 697 surgical patients aged ≥ 65 years were recruited 2014-2017 in Utrecht, the Netherlands and Berlin, Germany into the BioCog study. C-reactive protein (CRP), S100A12, interleukin-6 (IL-6) and IL-18 were measured immediately before surgery. POD was assessed twice daily up to 7 days/hospital discharge. POCD was determined from neuropsychological testing before surgery and 3 months thereafter. Multiple logistic regression analyses were run adjusted for age, sex, surgery site, and BMI. Results. 140 out of 697 patients (20.1%) developed POD during 7 days/by discharge; 50 out of 469 patients (10.9%) attending the 3-month follow-up developed POCD. CRP ≥ 10 mg/L was found in 149 patients and was not associated with POD/POCD. Among patients with CRP < 10 mg/L, higher S100A12 and higher CRP concentrations were each associated with higher POD risk (OR per SD higher concentrations, S100A12, 1.26, 95% CI 1.03, 1.54; CRP,1.42, 95% CI 1.15, 1.76). Higher S100A12 was associated with higher POCD risk (OR 1.40 per SD, 95% CI 1.04, 1.88). No associations were found for IL-6 and IL-18. Of note, only the result on CRP and POD survived Bonferroni correction with cut-off p < 0.006. Conclusion Low-grade inflammation may influence individual vulnerability to cognitive complications of surgery. Our results warrant further examination. Trial registration NCT02265263.

Indexed as

InflammationNeurocognitive DisordersPostoperative Cognitive ComplicationsPostoperative ComplicationsAgedAged, 80 and overBiomarkersCognitive DysfunctionC-Reactive ProteinDeliriumFemaleHumansInterleukin-18Interleukin-6MaleRisk FactorsBiomarkersC-Reactive ProteinInterleukin-18Interleukin-6S100A12 ProteinAgeingInflammationNeuroepidemiologyPostoperative cognitive dysfunctionPostoperative delirium

Identifiers

PMID41419753
PMCPMC12722205

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.